Summary:
Click image to enlarge
3 week (3 times a week) outpatient study at CBH Health located in Gaithersburg, MD. Purpose of study is to evaluate efficacy, safety and tolerability of Rapastinel as adjuntive therapy. If members respond well to investigational compound (RAPASTINEL) they will qualify for extension study (study could last up to two years with once a week visits).
Qualified Participants Must:
• Ages 18-65
•
Weight: 89-276lbs
•
Willing to complete 3 study visits per week for 3 weeks
•
Diagnosis of Major Depressive Disorder with current major depressive episode
•
Good physical health (some medical conditions stable with medications)
•
No seizure disorders, strokes or tumor of CNS
•
No lifetime history of any psychotic disorder
•
No suicide attempt within the last year
•
History of anitpsychotic treatments are exclusionary
Qualified Participants May Receive:
Potential stipend of $1,025 for completion of study.